Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
MARK3 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MARK3 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MARK3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPKAPK5 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPKAPK5 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPKAPK5 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MARCKS Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MARCKS Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MARCKS sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MELK Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MELK Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MELK sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MATK Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MATK Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MATK sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPK9 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPK9 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPK9 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPK7 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPK7 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPK7 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPKAPK2 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPKAPK2 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPKAPK2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPKAPK3 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPKAPK3 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPKAPK3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPK8 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPK8 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPK8 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPK4 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPK4 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPK4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MAPK15 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MAPK15 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of MAPK15 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →